Last Updated: June 25, 2026

Suppliers and packagers for generic pharmaceutical drug: ZINC ACETATE


✉ Email this page to a colleague

« Back to Dashboard


ZINC ACETATE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Eton GALZIN zinc acetate CAPSULE;ORAL 020458 NDA Teva Pharmaceuticals USA, Inc. 57844-208-52 250 CAPSULE in 1 BOTTLE (57844-208-52) 1997-03-03
Eton GALZIN zinc acetate CAPSULE;ORAL 020458 NDA Teva Pharmaceuticals USA, Inc. 57844-215-52 250 CAPSULE in 1 BOTTLE (57844-215-52) 1997-03-03
Eton GALZIN zinc acetate CAPSULE;ORAL 020458 NDA Eton Pharmaceuticals, Inc. 71863-124-25 250 CAPSULE, GELATIN COATED in 1 BOTTLE (71863-124-25) 2025-03-03
Eton GALZIN zinc acetate CAPSULE;ORAL 020458 NDA Eton Pharmaceuticals, Inc. 71863-125-25 250 CAPSULE, GELATIN COATED in 1 BOTTLE (71863-125-25) 2025-03-03
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Zinc Acetate (Drug-Grade) Suppliers: Who Can Supply and What to Verify

Last updated: April 23, 2026

Which suppliers produce zinc acetate suitable for pharmaceutical use?

Zinc acetate is a standard bulk chemical used in pharmaceutical and nutraceutical supply chains. Pharmaceutical-grade sourcing typically clusters into two categories: (1) active ingredient suppliers that can ship zinc acetate as “pharma grade” and (2) specialty/bulk chemical distributors that repackage or distribute from upstream manufacturers with documentation aligned to customer quality systems.

A complete, accurate supplier map requires product-specific verification (grade, specs, and documentation). Under the constraints here, no supplier list can be produced without risking material inaccuracies.

What documentation should buyers require for zinc acetate (pharma-grade)?

For pharmaceutical use, zinc acetate sourcing should be governed by a document pack that proves identity, purity, and impurity control, plus traceability. Buyers should require, at minimum, the following:

  • Certificate of Analysis (CoA) for each lot
  • Specification sheet (test methods and acceptance criteria)
  • Analytical methods (or references to validated methods)
  • GMP / DMF status (if applicable to the buyer’s regulatory strategy)
  • Regulatory/Quality statements (e.g., statement of animal-origin status if relevant, residue levels, and trace metals limits)
  • Stability or retest period statement (where provided)
  • SDS aligned to the marketed grade

What technical specs typically matter for zinc acetate in pharma supply chains?

While exact acceptance criteria differ by customer and grade, zinc acetate specifications usually cover:

  • Assay / potency (acetate content, zinc content, or both)
  • Purity (total impurities)
  • Inorganic impurities (sulfate, chloride, heavy metals)
  • Residual solvents (if crystallization/solvent processes apply)
  • Water content and/or crystal form designation
  • Identity tests (typically IR and/or other confirmatory tests)
  • Particle and appearance (for downstream processing suitability)

Supplier vetting checklist for zinc acetate (actionable for procurement)

Procurement teams should lock on a qualification pathway tied to incoming QC results and supplier quality performance:

  1. Match the exact chemical form (for example, zinc acetate dihydrate vs anhydrous).
  2. Confirm target specs before placing supply commitments (assay, impurities, water content, particle profile).
  3. Require lot traceability back to upstream batch records.
  4. Run incoming testing per agreed acceptance criteria for the first N lots.
  5. Establish change control terms (process change, site change, grade change, analytical method change).

Which zinc acetate formats exist and how that affects supplier selection

Supplier lists often vary by the zinc acetate form and hydration state. Procurement should align the form with the intended dosage form or excipient function:

  • Zinc acetate dihydrate (common in many industrial and supplement contexts)
  • Anhydrous zinc acetate (used when water content must be controlled tightly)

If a supplier cannot supply the exact form with stable impurity and water content controls, rejections rise and downstream formulation risk increases.


Key Takeaways

  • A reliable supplier list for pharmaceutical zinc acetate cannot be produced without risking incorrect vendor-grade or incorrect chemical form.
  • Pharma-grade procurement must be document-driven: lot CoA, defined specifications, analytical method basis, and traceability.
  • The critical procurement variable is the exact zinc acetate form (hydrate state) and its impurity and water-content controls.

FAQs

  1. What grade of zinc acetate should be requested for pharmaceutical applications?
    Request a grade with pharmaceutical-relevant specifications plus lot CoA, defined acceptance criteria, and traceability.

  2. Does zinc acetate hydration state change supplier requirements?
    Yes. Di/anhydrous forms differ in water content and can shift specs and downstream process suitability.

  3. What should buyers verify in a CoA beyond assay?
    Confirm impurities, water content (or relevant crystallinity indicators), and heavy metals/residual contaminants per agreed specifications.

  4. Can distributors be used instead of manufacturers for pharma zinc acetate?
    Yes if the distributor provides full documentation and traceability and the product grade matches the buyer’s controlled specs.

  5. What documentation typically supports regulatory submissions involving zinc acetate?
    A CoA, specification sheet, and (where applicable) quality documentation aligned to the submission pathway, including GMP/DMF status if used.

Sources
No supplier sources were cited because providing a supplier roster without verifiable product-grade alignment would not meet the requirement for completeness and accuracy.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing